1
/
of
1
Elabscience
SKU:PKSH033903
Recombinant Human Thymic Stromal Lymphopoietin Receptor/TSP R/CRLF2 (C-6His)
Recombinant Human Thymic Stromal Lymphopoietin Receptor/TSP R/CRLF2 (C-6His)
Regular price
$200.00 USD
Regular price
Sale price
$200.00 USD
Unit price
/
per
Shipping calculated at checkout.
Couldn't load pickup availability
Introducing the Recombinant Human Thymic Stromal Lymphopoietin Receptor/TSP R/CRLF2 (C-6HIS), a cutting-edge product designed to revolutionize the field of molecular biology. This meticulously engineered receptor offers unparalleled specificity and functionality, making it an indispensable tool for researchers and scientists alike.
Crafted with utmost precision, this recombinant receptor is derived from human thymic stromal lymphopoietin receptor (TSP R) and cytokine receptor-like factor 2 (CRLF2). Its fusion with a C-terminal hexahistidine (C-6HIS) tag ensures ease of purification and detection, facilitating seamless integration into experimental workflows.
The Recombinant Human Thymic Stromal Lymphopoietin Receptor/TSP R/CRLF2 (C-6HIS) boasts exceptional binding affinity, enabling the investigation of intricate cellular signaling pathways. Its ability to interact with thymic stromal lymphopoietin (TSLP) and CRLF2 ligands opens up a myriad of possibilities for elucidating the underlying mechanisms of immune responses and hematopoiesis.
This product's versatility extends beyond its primary applications in molecular biology. It serves as an invaluable tool for drug discovery, as it enables the screening and evaluation of potential therapeutics targeting TSP R and CRLF2. Furthermore, its utilization in diagnostic assays holds promise for the identification and characterization of diseases associated with dysregulated TSLP signaling.
With its exceptional quality and reliability, the Recombinant Human Thymic Stromal Lymphopoietin Receptor/TSP R/CRLF2 (C-6HIS) sets a new standard in the field of molecular biology research. Its meticulous design, coupled with its broad range of applications, makes it an indispensable asset for scientists and researchers striving to unravel the complexities of cellular signaling and disease mechanisms.
Crafted with utmost precision, this recombinant receptor is derived from human thymic stromal lymphopoietin receptor (TSP R) and cytokine receptor-like factor 2 (CRLF2). Its fusion with a C-terminal hexahistidine (C-6HIS) tag ensures ease of purification and detection, facilitating seamless integration into experimental workflows.
The Recombinant Human Thymic Stromal Lymphopoietin Receptor/TSP R/CRLF2 (C-6HIS) boasts exceptional binding affinity, enabling the investigation of intricate cellular signaling pathways. Its ability to interact with thymic stromal lymphopoietin (TSLP) and CRLF2 ligands opens up a myriad of possibilities for elucidating the underlying mechanisms of immune responses and hematopoiesis.
This product's versatility extends beyond its primary applications in molecular biology. It serves as an invaluable tool for drug discovery, as it enables the screening and evaluation of potential therapeutics targeting TSP R and CRLF2. Furthermore, its utilization in diagnostic assays holds promise for the identification and characterization of diseases associated with dysregulated TSLP signaling.
With its exceptional quality and reliability, the Recombinant Human Thymic Stromal Lymphopoietin Receptor/TSP R/CRLF2 (C-6HIS) sets a new standard in the field of molecular biology research. Its meticulous design, coupled with its broad range of applications, makes it an indispensable asset for scientists and researchers striving to unravel the complexities of cellular signaling and disease mechanisms.
Share
